Story perspectives

New Weight Loss Drug Targets Hormones for 30% Reduction

9/9/2025

50 11

Summary

Story summary

Tufts University researchers developed a weight loss drug targeting four hormones, aiming for improved effectiveness over GLP-1 medications.
The drug may enable weight loss of up to 30%, similar to bariatric surgery results.
It focuses on GLP-1, GIP, glucagon, and peptide YY (PYY) to regulate appetite and metabolism.
Current GLP-1 drugs cause side effects like nausea, leading to high dropout rates.
The new drug is in preclinical stages and has not yet entered human trials.
Experts stress the importance of personalized treatment for effective weight loss.
Obesity impacts over 40% of American adults and is associated with various health complications.

1 of 1

Story summary

Tufts University researchers developed a weight loss drug targeting four hormones, aiming for improved effectiveness over GLP-1 medications.
The drug may enable weight loss of up to 30%, similar to bariatric surgery results.
It focuses on GLP-1, GIP, glucagon, and peptide YY (PYY) to regulate appetite and metabolism.
Current GLP-1 drugs cause side effects like nausea, leading to high dropout rates.
The new drug is in preclinical stages and has not yet entered human trials.
Experts stress the importance of personalized treatment for effective weight loss.
Obesity impacts over 40% of American adults and is associated with various health complications.